Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thank you fer heads up
re;
https://www.otcmarkets.com/otcapi/company/dns/news/document/65670/content
$EBYH is looking like they will have a tremendous 2023.
Stock based on the float and outstanding is very undervalued.
They have three sources of revenue now; lease agreements, dispensary sales of both
CBD and THC for medical, and lastly their iOS APP that will feature AI .
I think that AI is rapidly expanding and that ChatGPT is now being investigated for every potential use. EBYH is involved with them and other AI platforms and we will soon see the results.
thank you fer heads up e-buy home
Would love to see this move upward.
Strainsforpains, Inc. Shareholder Update . New York, NY, January 12, 2023—
STRAINSFORPAINS,INC. ( OTC Markets: EBYH).
The company is pleased to announce that it has returned from the Consumer Electronics Show 2023 in Las Vegas where it successfully entered into agreements with various technology and retail entities within the health, wellness, and technology industries. The company will be updating its shareholders this quarter on the events.
We have entered into the next phase of our growth plan and we anticipate a substantial increase in revenues with the launch of the iOS version of our Strainsforpains cannabis app. This will include new business models that will take advantage of advertising versus a subscription model. The Beta testing for our iOS version is coming to a close and we are hopeful in seeing revenues that could reach millions of dollars. This will include income from various joint ventures, distribution of CBD products that will utilize our Pennsylvania facility, and our app revenues. “Our app will be expanding to hundreds of new and updated scientific and medical studies in pain management done globally over the past year,” said Mr. Shainberg, CEO of Strainsforpains, Inc.
Thank you Bansky - love your handle!!!!!
The updates and news mean they will be coming out with an Apple iOS version soon. Professionals in the health field use Apple phones. I think by January the stock will move. The tight share structure with any promotion will take this well above a dollar.
Thank you.
No reaction to the news and Q.
What do you make of the news and the Q?
thanks
https://www.strainsforpains.com/
Here we can open a DEMO of the APP by clicking on the smartphone image and scrolling to see even a clinical study on why that particular strain was suggested. They will be coming out with an Apple version of their App for the Las Vegas CES show in January 2023.
https://www.strainsforpains.com/videos/
They have updated their videos
https://www.strainsforpains.com/news/
They have updated their news articles
EBYH Third Quarter Financials
https://www.otcmarkets.com/otcapi/company/financial-report/352446/content
Strainsforpains, Inc. Shareholder Update . New York, NY, November 7, 2022— STRAINSFORPAINS,INC. ( OTC Markets: EBYH). On November 4, 2022
The Centers for Disease Control and Prevention issued new guidelines for health clinicians on how and when to prescribe opioids for pain relief. This report changes the 2016 recommendations which many doctors and patients criticized as too austere. The 2016 guidelines attempted to restrict the use of opioids and created untreated or undertreated pain. This new plan serves as a roadmap for physicians to navigate how to treat pain and chronic conditions. Although these new guidelines are voluntary they are attempting to not limit what is the best policy for the doctor to prescribe, including alternative pain medications. “
I believe that these new guidelines will not increase doctor’s prescriptions for opioid medicines but rather allow physicians and nurses to start seriously learning about alternatives like medical cannabis, to provide better care and relieve patients pain”, said Y. Simon Shainberg, CEO of Strainsforpains, Inc. “This new focus on individualized care”, said Mr. Shainberg, “will emphasize that treatment in many cases points to evidence that other treatments and approaches are comparable for improving pain and function”. While these guidelines are welcome their impact will depend on other federal and state agency’s responses to them. As such, Mr. Shainberg has been asked to contribute to a request for information (RFI) from the National Institute of Health as to their interest in barriers to research studies on the health effects of cannabis and its constituents. In this regard, Strainsforpains has developed an App for the healthcare community addressing best practices for recommendations of specific cannabis strains for individual pain management. The app will educate doctors, pharmacists, and health professionals as well as chronic pain sufferers with the tools needed to determine effective cannabis usage.
“There is a need for professionals to understand the safety and effectiveness of cannabis for medical indications. A major barrier is lack of knowledge in the field by health professionals”, said Mr. Shainberg. Mr. Shainberg has spent the last 15 years studying the effects of hundreds of cannabis strains on chronic pain sufferers. He is a member of the International Cannabinoid Research Society. “We believe that many patients who are using both THC and CBD in conjunction with opioids often feel far better, with fewer side effects than only using opioids”, said Mr. Shainberg.
Mr. Shainberg advises health professionals that their patients should always be advised to record their experience of use, including side effects observed and views regarding the impact of treatment. Ultimately a medical access program should collect this confidential data. Overview of Strainsforpains, Inc. Please visit our website at http://www.strainsforpains.com/ CDC November 4, 2022 Guidelines
https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm?s_cid=rr7103a1_w
National Institute of Health, National Center for Complimentary and Integrative Health
https://www.nccih.nih.gov/
International Cannabinoid Research Society https://icrs.co/
Strainsforpains Inc. Board appoints Samuel A. Epstein to SFP Board of Advisors. New York, N.Y.-April 8, 2022
Strainsforpains, Inc. (OTC PINK: EBYH) announced today that the Strainsforpains Board of Directors appoints Samuel A. Epstein to SFP’s Advisory Board. “Mr. Epstein, has a formidable background in environmental and energy issues, and will help advise and guide the company in its expansion in our future projects, alliances and joint ventures”, said Mr. Shainberg, CEO of Strainsforpains, Inc.
About Samuel Epstein: Mr. Epstein is based in New York City. He is the President and Founder of Geoval Consulting LLC, a firm that applies geological expertise and experience to evaluate prime target investment opportunities. Geoval utilizes geochemical analytical data and modeling for risk profiling to certify geological assets and property selection for private and public entities. He has over 40 publications, including work on experimental and field biogeochemical reactions in saltwater in respected scientific journals, with a focus on successfully merging geology with economic viability.
For over 30 years, Samuel Epstein served as an investment advisor an SVP for Merrill Lynch and Morgan Stanley. His certifications are from business graduate-level programs at Harvard, the University of Chicago, and U.C. Berkeley. He is a Certified Petroleum Geologist and Board Certified Professional Geoscientist. He is a member of the AAPG for over 42 years and a delegate representing New York State for over 9 years. He received an MS in Geology from Rensselaer Polytechnic Institute and for the past 20 years, serves on the Board of Governors for Touro College and University, and acting as an executive director of the Touro College Center for Environmental and Geological Research.
This baby never trades unfortunately - not even with news......
READING , HEADS UP $EBYH
THANK YOU $EBYH
$EBYH just released news: Here is part of that news release.
"Over the next weeks, the company will be announcing additional
staff as well as an energy advisory board.
Our facility has also been considered as to developing crypto mining
and cryptocurrency services.
As a result, we will be announcing a joint venture in the Spring of 2022.
Latest News:
Strainsforpains, Inc. Announces Shareholder Update. New York, NY, February 17, 2022, ( Symbol EBYH: OTC Mkts). Strainsforpains, Inc., a New York purveyor of enterprise-class technology solutions for the cannabis industry, is pleased to announce an update to the company’s business.
We will be releasing an iOS version for Apple phones In March 2022, of our telehealth App that helps educate consumers and health professionals as to the best pain medication choices for medical cannabis. The iOS version includes upgraded and added data to our current existing Android version.
In addition, our 6 acre Pennsylvania energy facility will be retrofitted for energy usage in the Spring of 2022. We are currently adding water purification equipment to the site and intend to announce joint ventures and contracts this Spring.
Over the next weeks, the company will be announcing additional staff as well as an energy advisory board. Our facility has also been considered as to developing crypto mining and cryptocurrency services. As a result, we will be announcing a joint venture in the Spring of 2022.
Our Pennsylvania facility is in close proximity to the Susquehanna nuclear power plant that recently announced a major crypto mining joint venture for the usage of up to 300 GW and the building of a massive data center to mine cryptocurrency.
Mr. Shainberg, CEO of Strainsforpains, stated that “we have diligently worked over the past year, on numerous joint ventures, acquisitions, and upgrades to both our telehealth and energy divisions. We expect that 2022 will be a substantial year for our company and its vision “.
yes E Buy Home Inc (PK) (EBYH)
0.59 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
0.26 0.588 - - -
EBYH Detailed Quote
yes E Buy Home Inc (PK) (EBYH)
0.59 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
0.26 0.588 - - -
EBYH Detailed Quote
EBYH is Pink Sheet Current
https://www.otcmarkets.com/stock/EBYH/overview
THANK YOU FER HEADS UP E Buy Home Inc (PK) (EBYH)
0.23 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
0.23 0.606 - - -
EBYH Detailed Quote
$EBYH market cap only $2.7m
https://www.otcmarkets.com/stock/EBYH/security
https://www.otcmarkets.com/otcapi/company/financial-report/306510/content
Strainsforpains, Inc. has filed Attorney Letter with respect to Current Information. Looks like EBYH will be a pink sheet current stock soon.
The science behind Cannasphere-Biotech LLC (their acquisition) Liposome technology can be read here:
https://cannaspherebiotech.com/lipofusion-advantages/scientific-overview-comparative-analysis/
Cannasphere Biotech Named by The Silicon Review Magazine as one of 50 Leading Companies of the Year 2021
https://thesiliconreview.com/magazine/profile/50-leading-companies-of-the-year-2021-listing
The Silicon Review Magazine is a trusted source of news and information for global business leaders, decision makers, and professionals. Business enterprises honored in the publication’s annual ranking of leading companies are selected based on their “contributions to the business community and efforts toward the ecosystem.”
$EBYH is on its way in acquisitions of high quality companies and products.
Cannasphere Biotech's goal is to help take the CBD market to the next level with products that really deliver. Unfortunately, consumers are often disappointed when the promises made by CBD brands don’t pan out. “Our patent pending Lipofusion™ delivery technology makes CBD much easier for the body to absorb and facilitates sustained relief so the benefits of CBD are enjoyed for hours.” (Star Simmons, CEO).
https://cannaspherebiotech.com/
Cannasphere Biotech is “ committed to harnessing science to produce breakthrough Cannabidiol (CBD) products that have a profoundly positive impact on humanity.Our water soluble CBD, made with patent pending Lipofusion™ delivery technology, can be utilized as a raw ingredient in a wide variety of formulations.We also offer private label CBD products that combine the power of CBD with our leading edge nanoliposomal delivery technology to maximize efficacy and deliver remarkable, reliable benefits”.
$EBYH Strainsforpains is expanding by acquisitions into liposome CBD markets.
Good news! $EBYH $$
$ebyh Strainsforpains, Inc. Enters into a Letter of Intent to Acquire Cannasphere Biotech, LLC and Commences Good Faith Negotiations and Pre-Purchase Due Diligence
EBYH
0.00%
Wed, August 11, 2021, 10:45 AM·4 min read
In this article:
EBYH
0.00%
NEW YORK, NY / ACCESSWIRE / August 11, 2021 / Strainsforpains, Inc. (OTC Markets:EBYH), a New York-based purveyor of enterprise-class technology solutions for the cannabis industry, announces that it has signeda letter of intent to acquire Cannasphere Biotech, LLC, an Arizona-based developer and manufacturer of water-soluble, nanoliposomal cannabinoid products serving business clients in the cannabis industry.Poised to emerge as a global player in the rapidly-growing cannabis and CBD markets, Strainsforpains is well-positioned with its database of cannabis cultivars and strain varietals to capitalize on Cannasphere's proprietary intellectual property, expertise in the cannabis space, and industry relationships. Distribution of Cannasphere Biotech's groundbreaking nanoliposomal cannabinoid products will assist Strainsforpains in expanding its business into several revenue-producing verticals.
"We are not just selling a product, we are fulfilling a need for information about the therapeutic utility of phyto-cannabinoids derived from all varieties of cannabis. Not only do the App and Database provide a platform where consumers can educate themselves about the medicinal effects of cannabinoids, they also provide a valuable resource for medical providers, product makers, growers and other industry stakeholders." said Simon Shainberg, CEO of Strainsforpains.
According to Shainberg, the portal will also provide an ideal marketing engine for Cannasphere Biotech, which is just one of many reasons the acquisition dovetails well with the company's strategic plan for expansion and explosive growth.
"Having been very impressed by the innovative nanoliposomal technology developed by Cannasphere Biotech, we believe this acquisition will add tremendous value to the Stransforpains portfolio," said Shainberg. "The synergy of combining resources of both companies will strengthen growth potential and position Cannasphere's products with an additional competitive advantage."
thank you fer heads up E Buy Home Inc (PK) (EBYH)
0.54 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
0.2761 0.608 - - -
EBYH Detailed Quote
$EBYH website-> www.strainsforpains.com/
Boom! $EBYH $$
EBYH Certificate of Reinstatement
05/19/2021 05:15 PM
Strainsforpains Inc.
Certificate of Reinstatement
Good news. Lots happening. Going to be fun soon $$ $EBYH $$
Strainsforpains Inc. shareholder announcement ( OTC Symbol: EBYH) New York, N.Y., May 20, 2021.
The company is pleased to announce further progress in its goal towards its strategy of becoming a distributor and marketer of CBD/CBG products. The company’s Pennsylvania property is in the process of being retrofitted into a production facility for these products. The company has been test marketing its CBD/CBG products and the response has been substantial.
The benefits of combining CBD and CBG together has been in line with the demand for higher quality products. “Our products will provide higher quality and exceptional health benefits for those looking for relief from pain. The combination of CBD and CBG balance each other’s benefits out. Our studies have shown that users had beneficial effect for both pain and depression”, said Yehoshua Shainberg.
Our Strainsforpains APP has continued to expand, and we will soon be announcing a joint venture with a medical organization that will exclusively utilize our technology for their patients. The company is excited for its future in educating health professionals to realize the thousands of variations of Canna products in combination with CBD/CBG that have beneficial results for those in pain.
The company is also pleased to announce that it has been negotiating with several sports and entertainment figures with regards to promotion of its products and services. We will announce in our second quarter, a list of NFL and entertainment figures, in Arizona and California, that will help us get to the next stage in our development, as a company that helps those in need with access to technology services and products.
The company is also pleased to announce that our president, Yehoshua Shainberg, is a member of the prestigious International Cannabinoid Research Society, and will be participating in this year’s annual ICRS conference. ICRS is made up of approximately 1600 MD’s, PhD’s, and those recognized for contributions in research and development in this field.
Cooled down a bit. But sign of the times with the .50 x .70 earlier $EBYH
$EBYH ...is involved in acquisitions within the cannabis and CBD industry.
$EBYH NEWS! The company will take advantage of the opportunities to increase shareholder values during our expansion process, with our new investment banking arrangements, upgrading of financial status as a reporting company, and our added real estate and manufacturing assets.
https://backend.otcmarkets.com/otcapi/company/dns/news/document/44406/content
Boom! ...we are looking forward to an extremely profitable year”. $$$ $EBYH $$$
Strainsforpains, Inc. ( OTC Symbol: EBYH) New York, N.Y., March 24, 2020.
Strainsforpains, Inc. is delighted in announcing that its telehealth APP has expanded its revenues, and has entered into joint ventures to further the company’s business plan. “We have been working with hemp farmers in a venture that will store and process hemp to CBD oil, at our Pennsylvania storage facility. Our Pennsylvania facility is being retrofitted for to be fully operational in April, and we are looking forward to an extremely profitable year”.
In further developments, The Trump administration and public officials are urging consumers to use telehealth services, to get remote treatment and medical attention during the current pandemic. Strainsforpains APP offers doctors, patients and dispensaries a streamlined way to select which cannabis strain would be best suited for their specific ailment. We are reporting a surge in demand for our services, and expect 2020 to be a banner year.
With social distancing, many more people are getting care, without going to a doctor, regarding pain decisions. 80% of hospitals have some sort of telehealth services. According to the California based center for Connected Health Policy, states are substantially easing the rules to allow residents to access telemedicine and telehealth services.
Strainsforpains believes that it is especially important in this time, where we are dealing with a fast moving virus that can threaten a large part of the population. Telemedicine allows a sick person or a person with pain, to communicate with a qualified health professional, without going to their office.
The company also has announced that it has accumulated $50,000 in prepaid postage, which will be utilized to offset expenses, in mailing and distributing our products during 2020 and beyond.
An Overview of Strainsforpains, Inc.
Please visit our website at http://www.strainsforpains.com/
Strainsforpains, Inc. is an innovative healthcare data technology company located in New York, N.Y. The Company's objectives are to provide doctors, nurses, dispensaries and patients access to an APP that will allow for an advanced determination of comparison of strains or brands of cannabis combinations with major illnesses, in a user friendly manner. The company also is involved in acquisitions within the cannabis and CBD industry.
Safe Harbor Statement Statements
Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Strainsforpains, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Strainsforpains, Inc. is unable to give any assurance that its expectations will be attained. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Strainsforpains, Inc's. ability to control and those actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Strainsforpains, Inc.’s filings with OTCmarkets.com, FINRA and the Securities and Exchange Commission. All annual reports (10Ks) and quarterly reports (10Qs) are filed and up to date and can be found at OTCmarkets.com website www.otcmarkets.com .
Company contact: Yeshua Shainberg 646-481- 4161
E Buy Home Inc (PK) (EBYH)
0.3193 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
0.132 0.318 - - -
EBYH Detailed Quote
THANK YOU FOR HEADS UP.
$EBYH, thank you , review is very good.
Can we expect a Strainsforpains, Inc. news release by Monday morning?
Remember that they are a telehealth company with a successful APP dealing with pain medicine recommendations within the cannabis space. That can expand beyond cannabis.
I am also researching their real estate which is being transformed into a hemp to CBD warehouse, extraction and CED production.
In these trying times, we are seeing major interested in telemedicine and telehealth ( as well as ZOOM like online education companies) as well as investing in CBD and weed companies.
reading, $EBYH
Good morning mick. Go $EBYH
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1039
|
Created
|
05/02/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |